G P Gui
Impact in
- Genetics top 10%
- Estrogen and related hormone effects
- Inflammatory Bowel Disease
-
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
Papers in
- Co-authors
- Jeremy Sanderson (1 shared paper)J P Lake (1 shared paper)Mark Tizard (1 shared paper)John Hermon-Taylor (1 shared paper)P. Thomas (1 shared paper)Mitch Dowsett (1 shared paper)Janine Salter (1 shared paper)Mike J. Dixon (1 shared paper)
- Journals
- Health Technology Assessment (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Medical Entomology and Zoology (1 paper)PubMed (8 papers)
- Partner nations
- United KingdomTaiwanGreece
In The Last Decade
G P Gui
11 papers receiving 373 citations
Peers
Comparison fields: 5 of 60
- Genetics 181
- Oncology 163
- Cancer Research 88
- Pharmacology 28
- Epidemiology 91
Countries citing papers authored by G P Gui
This map shows the geographic impact of G P Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G P Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G P Gui more than expected).
Fields of papers citing papers by G P Gui
This network shows the impact of papers produced by G P Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G P Gui. The network helps show where G P Gui may publish in the future.
Co-authors
The 25 scholars most cited alongside G P Gui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer. | 2001 | 150 |
| 2 | 1997 | 127 | |
| 3 | Is cholecystectomy effective treatment for symptomatic gallstones? Clinical outcome after long-term follow-up. | 1998 | 34 |
| 4 | One-stop diagnosis for symptomatic breast disease. | 1995 | 32 |
| 5 | Clinical audit of a specialist symptomatic breast clinic. | 1995 | 14 |
| 6 | 2013 | 12 | |
| 7 | Wire localisation biopsy of non-palpable breast lesions: reasons for unsuccessful excision. | 2006 | 8 |
| 8 | Surgical technique. Intracorporeal laparoscopic-guided feeding jejunostomy. | 1997 | 8 |
| 9 | Communication between hospital and general practitioners after day case surgery: a patient safety issue. | 1999 | 3 |
| 10 | Assessment of the common bile duct before cholecystectomy: a direct comparison between ultrasonography and intravenous cholangiography. | 1995 | 2 |
| 11 | Two-year-outcomes analysis of Crohn's disease treated with refabutin and macrolide antibiotics | 1997 | 2 |
About G P Gui
G P Gui is a scholar working on Genetics, Oncology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 11 papers that have together received 392 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (2 papers), Breast Cancer Treatment Studies (2 papers), Biliary and Gastrointestinal Fistulas (2 papers), BRCA gene mutations in cancer (2 papers), Global Cancer Incidence and Screening (2 papers), Gallbladder and Bile Duct Disorders (2 papers), Breast Lesions and Carcinomas (2 papers) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Genetics (181 citations), Oncology (163 citations), Cancer Research (88 citations), Pharmacology (28 citations) and Epidemiology (91 citations). G P Gui has collaborated with scholars based in United Kingdom, Taiwan and Greece. Frequent co-authors include Jeremy Sanderson, J P Lake, Mark Tizard, John Hermon-Taylor, P. Thomas, Mitch Dowsett, Janine Salter, Mike J. Dixon, Margaret Hills and Irene Boeddinghaus. Their work appears in journals such as Health Technology Assessment, Journal of Antimicrobial Chemotherapy, Medical Entomology and Zoology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.